QRS Duration or QRS Morphology: What Really Matters in Cardiac Resynchronization Therapy?

The beneficial effects of cardiac resynchronization therapy (CRT) have been well established in large, randomized trials. Despite the documented success of this treatment strategy, a significant proportion of patients with heart failure do not achieve the desired response. The aim of this review was to delineate factors contributing to a successful CRT response, emphasizing the interrelated roles of QRS morphology and QRS interval duration. More data are available on QRS duration, as this factor has been used as an enrollment criterion in clinical trials. Response to CRT seems to increase as the QRS duration becomes longer, with greatest benefit in QRS duration ≥150 ms. Recent data have placed more emphasis on QRS morphology, demonstrating variability in clinical response between patients with left bundle branch block, non-left bundle branch block, and right bundle branch block morphology. Notably, myocardial scarring and cardiac dimensions, among other variables, may alter heterogeneity in ventricular activation. Understanding the electrophysiological underpinnings of the QRS complex has become important not only to predict response but also to facilitate the patient-specific delivery of resynchronization therapy.

[1]  D. Simon,et al.  Effect of QRS Morphology on Clinical Event Reduction With Cardiac Resynchronization Therapy: Meta-Analysis of Randomized Controlled Trials , 2011 .

[2]  P. Tchou,et al.  Abstract 4342: The RethinQ Trial Echocardiographic Sub Study: Insights from Analysis of TDI Data on Mechanical Dyssynchrony in a Randomized Clinical Trial of Cardiac Resynchronization Therapy in Narrow QRS Patients with Heart Failure , 2008 .

[3]  Jagmeet P. Singh,et al.  QRS morphology, left ventricular lead location, and clinical outcome in patients receiving cardiac resynchronization therapy. , 2013, European heart journal.

[4]  J. Schroeder,et al.  Effects of Cardiac Resynchronization on Disease Progression in Patients With Left Ventricular Systolic Dysfunction, an Indication for an Implantable Cardioverter-Defibrillator, and Mildly Symptomatic Chronic Heart Failure , 2004, Circulation.

[5]  R. Lazzara,et al.  The Benefit of Cardiac Resynchronization Therapy and QRS Duration: A Meta‐Analysis , 2012, Journal of cardiovascular electrophysiology.

[6]  L. Lund,et al.  Gender, underutilization of cardiac resynchronization therapy, and prognostic impact of QRS prolongation and left bundle branch block in heart failure. , 2015, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[7]  Thomas Lavergne,et al.  Long-term benefits of biventricular pacing in congestive heart failure: results from the MUltisite STimulation in cardiomyopathy (MUSTIC) study. , 2002, Journal of the American College of Cardiology.

[8]  S. Solomon,et al.  Implantation Trial With Cardiac Resynchronization Therapy) Trial , 2011 .

[9]  Goldberger Jj,et al.  Cardiac-resynchronization therapy in heart failure with a narrow QRS complex. , 2014 .

[10]  N. Varma Left ventricular conduction delays and relation to QRS configuration in patients with left ventricular dysfunction. , 2009, The American journal of cardiology.

[11]  David G Strauss,et al.  Defining left bundle branch block in the era of cardiac resynchronization therapy. , 2011, The American journal of cardiology.

[12]  K. Bilchick Does Cardiac Resynchronization Therapy Benefit Patients With Right Bundle Branch Block: Left Ventricular Free Wall Pacing: Seldom Right for Right Bundle Branch Block , 2014, Circulation. Arrhythmia and electrophysiology.

[13]  J. Daubert,et al.  Effect of QRS Duration and Morphology on Cardiac Resynchronization Therapy Outcomes in Mild Heart Failure: Results From the Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction (REVERSE) Study , 2012, Circulation.

[14]  Jagmeet P. Singh,et al.  Left ventricular lead electrical delay predicts response to cardiac resynchronization therapy. , 2006, Heart rhythm.

[15]  A. Ha,et al.  Cardiac resynchronization therapy in patients with left ventricular systolic dysfunction and right bundle branch block: a systematic review. , 2011, Heart rhythm.

[16]  Udo Hoffmann,et al.  Quantitative analysis of intraventricular dyssynchrony using wall thickness by multidetector computed tomography. , 2008, JACC. Cardiovascular imaging.

[17]  Stefan Sack,et al.  Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. , 2002, Journal of the American College of Cardiology.

[18]  Kenneth A. Ellenbogen,et al.  The relationship between ventricular electrical delay and left ventricular remodelling with cardiac resynchronization therapy , 2011, European heart journal.

[19]  G. Wells,et al.  Impact of QRS Morphology and Duration on Outcomes After Cardiac Resynchronization Therapy: Results From the Resynchronization–Defibrillation for Ambulatory Heart Failure Trial (RAFT) , 2013, Circulation. Heart failure.

[20]  S. Saba,et al.  Usefulness of echocardiographically guided left ventricular lead placement for cardiac resynchronization therapy in patients with intermediate QRS width and non-left bundle branch block morphology. , 2014, The American journal of cardiology.

[21]  D. Delurgio,et al.  Cardiac resynchronization in chronic heart failure. , 2002, The New England journal of medicine.

[22]  S. Solomon,et al.  Survival with cardiac-resynchronization therapy in mild heart failure. , 2014, The New England journal of medicine.

[23]  Lluís Mont,et al.  2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). , 2013, European heart journal.

[24]  P. Tchou,et al.  Cardiac-resynchronization therapy in heart failure with narrow QRS complexes. , 2007, The New England journal of medicine.

[25]  A. Moss,et al.  Sex Differences in Long-Term Outcomes With Cardiac Resynchronization Therapy in Mild Heart Failure Patients With Left Bundle Branch Block , 2015, Journal of the American Heart Association.

[26]  S. Solomon,et al.  Predictors of Response to Cardiac Resynchronization Therapy in the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) , 2011, Circulation.

[27]  Milton Packer,et al.  Cardiac resynchronization in chronic heart failure. , 2002, The New England journal of medicine.

[28]  Stefano Ghio,et al.  Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms. , 2008, Journal of the American College of Cardiology.

[29]  Laura G. Qualls,et al.  QRS duration, bundle-branch block morphology, and outcomes among older patients with heart failure receiving cardiac resynchronization therapy. , 2013, JAMA.

[30]  P. Tchou,et al.  Probability and magnitude of response to cardiac resynchronization therapy according to QRS duration and gender in nonischemic cardiomyopathy and LBBB. , 2014, Heart rhythm.

[31]  David Begley,et al.  Targeted left ventricular lead placement to guide cardiac resynchronization therapy: the TARGET study: a randomized, controlled trial. , 2012, Journal of the American College of Cardiology.

[32]  R. Canby,et al.  Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. , 2003, JAMA.

[33]  J. Sturdivant Left Ventricular Versus Simultaneous Biventricular Pacing in Patients With Heart Failure and a QRS Complex ≥120 Milliseconds , 2012 .

[34]  E. Foster,et al.  Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias. , 2003, Journal of the American College of Cardiology.

[35]  C A Bucknall,et al.  Non-contact left ventricular endocardial mapping in cardiac resynchronisation therapy , 2003, Heart.

[36]  Thomas Guarnieri,et al.  Influence of Left Ventricular Lead Location on Outcomes in the COMPANION Study , 2009, Journal of cardiovascular electrophysiology.

[37]  Jeroen J. Bax,et al.  Results of the Predictors of Response to CRT (PROSPECT) Trial , 2008, Circulation.

[38]  A. Ducharme,et al.  Left Ventricular Versus Simultaneous Biventricular Pacing in Patients With Heart Failure and a QRS Complex ≥120 Milliseconds , 2011, Circulation.

[39]  Wojciech Zareba,et al.  Cardiac-resynchronization therapy for the prevention of heart-failure events. , 2009, The New England journal of medicine.

[40]  S. Saba,et al.  Effect of echocardiography-guided left ventricular lead placement for cardiac resynchronization therapy on mortality and risk of defibrillator therapy for ventricular arrhythmias in heart failure patients (from the Speckle Tracking Assisted Resynchronization Therapy for Electrode Region [STARTER] tr , 2014, The American journal of cardiology.

[41]  I. Diemberger,et al.  A Randomized Study of Cardiac Resynchronization Therapy Defibrillator Versus Dual-Chamber Implantable Cardioverter-Defibrillator in Ischemic Cardiomyopathy With Narrow QRS: The NARROW-CRT Study , 2013, Circulation. Arrhythmia and electrophysiology.

[42]  Wojciech Zareba,et al.  Left Ventricular Lead Position and Clinical Outcome in the Multicenter Automatic Defibrillator Implantation Trial–Cardiac Resynchronization Therapy (MADIT-CRT) Trial , 2011, Circulation.

[43]  A. Moss,et al.  PR Interval Identifies Clinical Response in Patients With Non–Left Bundle Branch Block: A Multicenter Automatic Defibrillator Implantation Trial–Cardiac Resynchronization Therapy Substudy , 2014, Circulation. Arrhythmia and electrophysiology.

[44]  A. Auricchio,et al.  Right and Left Ventricular Activation Sequence in Patients with Heart Failure and Right Bundle Branch Block:
A Detailed Analysis Using Three‐Dimensional Non‐Fluoroscopic Electroanatomic Mapping System , 2005, Journal of cardiovascular electrophysiology.

[45]  Olivier Gérard,et al.  Integrating functional and anatomical information to guide cardiac resynchronization therapy , 2010, European journal of heart failure.

[46]  Mark A Hlatky,et al.  2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. , 2013, Circulation.

[47]  J. Daubert,et al.  The effect of cardiac resynchronization on morbidity and mortality in heart failure. , 2005, The New England journal of medicine.

[48]  Jagmeet P. Singh,et al.  Potential uses of computed tomography for management of heart failure patients with dyssynchrony. , 2008, Critical pathways in cardiology.

[49]  D. Rowland,et al.  Effect of QRS morphology on clinical event reduction with cardiac resynchronization therapy: meta-analysis of randomized controlled trials. , 2012, American heart journal.

[50]  Kenneth C Bilchick,et al.  Bundle-Branch Block Morphology and Other Predictors of Outcome After Cardiac Resynchronization Therapy in Medicare Patients , 2010, Circulation.

[51]  John L Sapp,et al.  Cardiac-resynchronization therapy for mild-to-moderate heart failure. , 2010, The New England journal of medicine.

[52]  S. Saba,et al.  Identification of Typical Left Bundle Branch Block Contraction by Strain Echocardiography Is Additive to Electrocardiography in Prediction of Long-Term Outcome After Cardiac Resynchronization Therapy. , 2015, Journal of the American College of Cardiology.

[53]  D. DeMets,et al.  Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. , 2004, The New England journal of medicine.

[54]  J. Ge,et al.  Meta-analysis of randomized controlled trials comparing isolated left ventricular and biventricular pacing in patients with chronic heart failure. , 2011, The American journal of cardiology.

[55]  A. Greenspon,et al.  Cardiac resynchronization therapy in patients with right bundle branch block: analysis of pooled data from the MIRACLE and Contak CD trials. , 2005, Heart rhythm.

[56]  Angelo Auricchio,et al.  Characterization of Left Ventricular Activation in Patients With Heart Failure and Left Bundle-Branch Block , 2004, Circulation.

[57]  Paul J. Wang,et al.  Effectiveness of Cardiac Resynchronization Therapy by QRS Morphology in the Multicenter Automatic Defibrillator Implantation Trial–Cardiac Resynchronization Therapy (MADIT-CRT) , 2011, Circulation.

[58]  N. Freemantle,et al.  Surface electrocardiogram to predict outcome in candidates for cardiac resynchronization therapy: a sub‐analysis of the CARE‐HF trial , 2009, European journal of heart failure.

[59]  G. Boriani,et al.  A randomized double-blind comparison of biventricular versus left ventricular stimulation for cardiac resynchronization therapy: the Biventricular versus Left Univentricular Pacing with ICD Back-up in Heart Failure Patients (B-LEFT HF) trial. , 2010, American heart journal.

[60]  Jagmeet P. Singh,et al.  Biventricular pacing: current trends and future strategies. , 2012, European heart journal.

[61]  A. Ducharme,et al.  Cardiac Resynchronization Therapy in Patients With Heart Failure and a QRS Complex <120 Milliseconds: The Evaluation of Resynchronization Therapy for Heart Failure (LESSER-EARTH) Trial , 2013, Circulation.

[62]  Josef Kautzner,et al.  The Spectrum of Inter‐ and Intraventricular Conduction Abnormalities in Patients Eligible for Cardiac Resynchronization Therapy , 2004, Pacing and clinical electrophysiology : PACE.